We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Whistleblower: Mallinckrodt Concealed Vital Information to Drive Acthar Sales
Whistleblower: Mallinckrodt Concealed Vital Information to Drive Acthar Sales
A whistleblower lawsuit accuses Mallinckrodt of systemically concealing concerns about the composition of its drug Acthar, indicated for treatment of infantile spasms.